Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Cellular Biomedicine Inc
Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc Share News

$18.11 0.2  1.3%

Last Trade - 15/01/21

Sector
Healthcare
RiskRating
Adventurous
Size
Small Cap
Style
Sucker Stock
Market Cap £259.6m
Enterprise Value £275.7m
Revenue £238k
Position in Universe 3633rd / 6547
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions CBMG Dividends
All News
All News Reuters News Company Announcements
BRIEF-Cellular Biomedicine to provide update on CD20 CAR-T phase IIa trial
23rd Oct '15 News
BRIEF-Cellular Biomedicine announces positive results from CAR-T EGFR immunotherapy
28th Sep '15 News
BRIEF-Cellular Biomedicine Q2 loss per share $0.44
14th Aug '15 News
BRIEF-Cbmg announces certifications for proprietary cell and tissue preservation media kits
27th Jul '15 News
BRIEF-Cellular Biomedicine enters agreement to acquire cd40lgvax vaccine and related technologies
9th Jun '15 News
BRIEF-Cellular Biomedicine announces publication of Human Adipose-Derived Progenitor Cells to Treat Knee Osteoarthritis
5th Jun '15 News
BRIEF-Cellular Biomedicine CAR-T therapy succeeds early study
22nd May '15 News
BRIEF-Cellular Biomedicine reports Q1 loss per share $0.39
18th May '15 News
BRIEF-Cellular Biomedicine responds to class action lawsuit
30th Apr '15 News
BRIEF-Cellular Biomedicine says gmp laboratory, production facility in Shanghai passed China food and drug administration inspection
6th Apr '15 News
BRIEF-Cellular Biomedicine announces Phase I results from CAR-T immuno-oncology clinical development
25th Mar '15 News
BRIEF-Cellular Biomedicine announces interim results from Phase IIb clinical trial for knee osteoarthritis stem cell Rejoin therapy
25th Mar '15 News
BRIEF-Cellular Biomedicine says unit entered technology transfer agreement
9th Feb '15 News
BRIEF-Cellular Biomedicine starts patient recruitment for cartilage damage stem cell therapy clinical research
6th Jan '15 News
BRIEF-Cellular Biomedicine announces exercise of stock options to purchase common stock
23rd Dec '14 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.